Carisoprodol
Product Images NDC 67296-0271

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Carisoprodol (NDC 67296-0271). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Copy Of Label (6729602711)

Copy Of Label (6729602711)
Carisoprodol 350 mg tablet label showing 28 tablets per package. The label includes the NDC 67296-0271-1, a lot number 60909A 1, and expiration date 09/11. It lists Qualitest Pharmaceuticals as the manufacturer in Huntsville, AL, and Redpharm Drug in Eden Prairie, MN as the distributor. Storage instructions indicate 20-25°C (68-77°F) controlled room temperature.*
FDA Label Image

This In An Image Of The Structural Formula Of Carisoprodol. (Carisoprodol 1)

This In An Image Of The Structural Formula Of Carisoprodol. (Carisoprodol 1)
Chemical structure diagram of carisoprodol showing the molecular formula and the arrangement of its functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.